Frank Leonard
CEO & DirectorMr. Francis Leonard, also known as Frank, served as President of NovoCure Limited from 2025 to December 01, 2025 and serves as its Chief Executive Officer from December 01, 2025 and is its Director since June 03, 2026. Mr. Leonard joined the NovoCure Limited in 2010. Mr. Leonard was President of CNS Cancers U.S. of NovoCure Limited from 2022 until January 1, 2024 and served as Executive Vice President and President of Novocure Oncology since January 1, 2024 until 2025. He was Chief Development Officer of NovoCure Limited from September 2020 to 2022, a newly created executive role with responsibility for engineering, product development, business development and the overall strategic and operational leadership of Novocure?s innovation platforms. Mr. Leonard joined Novocure in 2010 to help prepare for the commercial launch of Optune? and served as the Senior Vice President for Corporate Strategy and Health Policy. In this role, he established Novocure?s health policy and business development groups and additionally led various finance functions. Prior to joining Novocure, Mr. Leonard was a venture capital investor focused on high-impact medical technologies. Mr. Leonard Leonard was an Associate at WFD Ventures LLC. He joined in 2004 and was previously an Analyst at the firm. Prior to this, Mr. Leonard served as an Analyst at InSight Venture Partners, working in both business process outsourcing and information technology investments. Mr. Leonard holds an A.B. from Harvard and an M.A. from the London School of Economics and Political Science.
Positions
- Company NameNovoCure LimitedStock CodeNVCRPositionCEO & DirectorColleagues
- WFWilliam F. DoyleExecutive Chairman
- CBChristoph BrackmannChief Financial Officer
- MPMichael PuriChief Human Resources Officer
- UWUri WeinbergChief Innovation Officer & Chief Medical Officer
- KGKinyip Gabriel LeungIndependent Director
- MJMartin J. MaddenIndependent Director
- JLJeryl Lynn HillemanIndependent Director
